{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:28:57Z","timestamp":1791332937113,"version":"4.3.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002480","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T21:56:51Z","timestamp":1327615011000},"page":"e1002480","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":101,"title":["Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy"],"prefix":"10.1371","volume":"8","author":[{"given":"Sonja","family":"Tattermusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Chaussabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Banchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finlay W.","family":"McNab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"O'Garra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R. M.","family":"Bangham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13550280390194028","article-title":"Human T-cell lymphotropic virus type I and neurological diseases.","volume":"9","author":"M Nagai","year":"2003","journal-title":"J Neurovirol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1038\/sj.onc.1208972","article-title":"HTLV-1 tropism and envelope receptor.","volume":"24","author":"N Manel","year":"2005","journal-title":"Oncogene"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I.","volume":"12","author":"CR Bangham","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"ref4","first-page":"1003","article-title":"Infiltration of helper inducer lymphocytes-T heralds central-nervous-system damage in Human T-cell Leukemia-Virus infection.","volume":"140","author":"Y Iwasaki","year":"1992","journal-title":"Am J Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.","volume":"52","author":"SL Hauser","year":"2006","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP.","volume":"4","author":"M Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","article-title":"High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis.","volume":"99","author":"PKC Goon","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4(+)FoxP3(+) cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response.","volume":"111","author":"F Toulza","year":"2008","journal-title":"Blood"},{"key":"ref9","first-page":"121","article-title":"Natural-killer (NK) cells in HTLV-I-associated myelopathy tropical spastic paraparesis - decrease in NK cell subset populations and activity in HTLV-I seropositive individuals J Neurovirol","volume":"33","author":"F Yu","year":"1991"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V99.1.88","article-title":"Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP).","volume":"99","author":"Y Yamano","year":"2002","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1000027","DOI":"10.1371\/journal.ppat.1000027","article-title":"HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM\/TSP.","volume":"4","author":"KN Meekings","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref12","first-page":"973-U998","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.","volume":"466","author":"MPR Berry","year":"2010","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev-immunol-030409-101221","article-title":"A genomic approach to human autoimmune diseases.","volume":"28","author":"V Pascual","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2006-02-002477","article-title":"Gene expression patterns in blood leukocytes discriminate patients with acute infections.","volume":"109","author":"O Ramilo","year":"2007","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/JVI.64.11.5682-5687.1990","article-title":"Invivo cellular tropism of Human T-cell Leukemia-Virus Type-1.","volume":"64","author":"JH Richardson","year":"1990","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1001177","DOI":"10.1371\/journal.ppat.1001177","article-title":"HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).","volume":"6","author":"S Oliere","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1038\/sj.onc.1208507","article-title":"IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1.","volume":"24","author":"MM Fung","year":"2005","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.M109.031476","article-title":"Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 Pathways.","volume":"285","author":"S Suzuki","year":"2010","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/JVI.02013-07","article-title":"Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.","volume":"82","author":"M Baba","year":"2008","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4049\/jimmunol.1002570","article-title":"Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.","volume":"186","author":"S Rahman","year":"2011","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.200907","article-title":"Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.","volume":"286","author":"A Refaat","year":"2011","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2741\/3420","article-title":"The immune control of HTLV-1 infection: selection forces and dynamics.","volume":"14","author":"CR Bangham","year":"2009","journal-title":"Front Biosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.","volume":"96","author":"KJM Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-6-35","article-title":"Induction of p21(CIP1\/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization.","volume":"6","author":"L Zhang","year":"2009","journal-title":"Retrovirology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2005-06-2567","article-title":"HTLV-1 tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).","volume":"107","author":"A Krueger","year":"2006","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bjo.78.2.149","article-title":"Human T lymphotropic virus type 1 uveitis.","volume":"78","author":"M Mochizuki","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/hmg\/ddq090","article-title":"The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.","volume":"19","author":"KS Gandhi","year":"2010","journal-title":"Hum Mol Gen"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus.","volume":"29","author":"D Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","article-title":"Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)\/tropical spastic paraparesis (HAM\/TSP) disease from HTLV-1 carrier state.","volume":"145","author":"JB Guerreiro","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2004.10.011","article-title":"CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.","volume":"159","author":"K Narikawa","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: crucial participants in disease amplification in autoimmunity.","volume":"6","author":"JC Hall","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.","volume":"89","author":"RE Randall","year":"2008","journal-title":"J Gen Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"D852","DOI":"10.1093\/nar\/gkn732","article-title":"INTERFEROME: the database of interferon regulated genes.","volume":"37","author":"SA Samarajiwa","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals.","volume":"2","author":"JM Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/glia.21076","article-title":"Interferon Lambda Inhibits Herpes Simplex Virus Type I Infection of Human Astrocytes and Neurons.","volume":"59","author":"JL Li","year":"2011","journal-title":"Glia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.","volume":"66","author":"TC van der Pouw Kraan","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.","volume":"100","author":"EC Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum.","volume":"62","author":"S Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome.","volume":"10","author":"ES Emamian","year":"2009","journal-title":"Genes Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08916930310001602137","article-title":"Potential mechanisms of interferon-alpha induced autoimmunity.","volume":"36","author":"B Conrad","year":"2003","journal-title":"Autoimmunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm0502-509","article-title":"Autoimmunity due to molecular mimicry as a cause of neurological disease.","volume":"8","author":"MC Levin","year":"2002","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.0900069","article-title":"The avidity and lytic efficiency of the CTL response to HTLV-1.","volume":"182","author":"T Kattan","year":"2009","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.gene.6364324","article-title":"A subtype of multiple sclerosis defined by an activated immune defense program.","volume":"7","author":"LGM van Baarsen","year":"2006","journal-title":"Genes Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/cir076","article-title":"Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More.","volume":"52","author":"BL Pearlman","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.0b013e3181c97d99","article-title":"Interferon-beta mechanisms of action in multiple sclerosis.","volume":"74","author":"S Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"key":"ref46","first-page":"161","article-title":"Prospects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.","volume":"13","author":"F Martin","year":"2011","journal-title":"AIDS Rev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1128\/JVI.02564-08","article-title":"Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I Interferon.","volume":"83","author":"S Kinpara","year":"2009","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.","volume":"7","author":"M Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","article-title":"Molecular mechanisms of cellular transformation by HTLV-1 Tax.","volume":"24","author":"R Grassmann","year":"2005","journal-title":"Oncogene"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"43620","DOI":"10.1074\/jbc.M307275200","article-title":"The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.","volume":"278","author":"J Basbous","year":"2003","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.onc.1208297","article-title":"HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.","volume":"24","author":"J Matsumoto","year":"2005","journal-title":"Oncogene"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood-2005-11-4551","article-title":"Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.","volume":"107","author":"J Arnold","year":"2006","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-6-19","article-title":"In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP).","volume":"6","author":"M Saito","year":"2009","journal-title":"Retrovirology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2007.12.036","article-title":"Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.","volume":"374","author":"X Feng","year":"2008","journal-title":"Virology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1128\/JVI.00007-11","article-title":"Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.","volume":"85","author":"S Charoenthongtrakul","year":"2011","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc2716","article-title":"Tumour suppression by p53: a role for the DNA damage response?","volume":"9","author":"DW Meek","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-5-76","article-title":"The HTLV-1 Tax interactome.","volume":"5","author":"M Boxus","year":"2008","journal-title":"Retrovirology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-5793(97)00280-9","article-title":"Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.","volume":"406","author":"T Akagi","year":"1997","journal-title":"FEBS Lett"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/JVI.02331-07","article-title":"Human T-cell leukemia virus type 1 Tax attenuates the ATM-mediated cellular DNA damage response.","volume":"82","author":"C Chandhasin","year":"2008","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cyto.a.20167","article-title":"Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations.","volume":"67A","author":"S Chow","year":"2005","journal-title":"Cytometry A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.157.1","article-title":"Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I.","volume":"157","author":"B Lee","year":"1989","journal-title":"Tohoku J Exp Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.2910370107","article-title":"Antigens related to three core proteins of HTLV-I (p24, p19 and p15) and their intracellular localizations, as defined by monoclonal antibodies.","volume":"37","author":"Y Tanaka","year":"1986","journal-title":"Int J Cancer"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T08:49:21Z","timestamp":1593593361000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002480"}},"subtitle":[],"editor":[{"given":"Susan R.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002480","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}